NAD and energy metabolism : Shown to increase intracellular NAD levels by up to 1.6-fold, supporting mitochondrial function and cellular energy production
For anyone with hypertension, even controlled hypertension, phentermine adds cardiovascular risk that semaglutide avoids
(It should be noted, however, that only male subjects were included in the first four trials.) But heres the catch: While scientists have currently found no alarm-sounding safety issues for AOD-9604, they also havent found evidence that the peptide actually helps you lose weight
If you want the full regulatory picture, see our Irish researchers guide to peptide legality
Headaches Nausea or vomiting Swelling and pain at the site of the injection Skin rashes Slight pain in the joints Stomach upset and diarrhea Ask for your doctors advice if side effects occur
It follows the same regulatory arc as BPC-157 and TB-500: Category 2 placement in 2023, removal from Category 2 in April 2026, and formal PCAC review scheduled for July 23, 2026
